Parkinson's Disease Trial, Recruiting (NCT07619560)

Parkinson's Disease Trial, Recruiting NCT07619560 Sponsor: Taipei Medical University Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07619560 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 30 and 85 years old
You have been diagnosed with early-stage Parkinson's disease (stages 1 to 3 on a standard scale used by doctors to measure how far the condition has progressed)
A brain scan (MRI) has shown changes in a specific area of the brain linked to Parkinson's disease, and you have never had a stroke
Your Parkinson's disease symptoms improve when taking Parkinson's medications, such as Levodopa
You do not currently have any serious or sudden-onset illnesses
You are able to take part in a 12-week programme and attend all required check-ins and assessments

Who may not be able to join:

You have difficulty completing interviews or have significant problems with movement or mobility
You have a serious or sudden illness before or during the study
You have a current gut or intestinal infection, such as C. difficile, E. coli, Salmonella, or certain other infections (confirm with trial site)
You are allergic to the product being tested in this trial (confirm with trial site for details on what the product contains)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02-27361661

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07619560

Sponsor: Taipei Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 02-27361661

More information: https://clinicaltrials.gov/study/NCT07619560

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 30 and 85 years old
You have been diagnosed with early-stage Parkinson's disease (stages 1 to 3 on a standard scale used by doctors to measure how far the condition has progressed)
A brain scan (MRI) has shown changes in a specific area of the brain linked to Parkinson's disease, and you have never had a stroke
Your Parkinson's disease symptoms improve when taking Parkinson's medications, such as Levodopa
You do not currently have any serious or sudden-onset illnesses
You are able to take part in a 12-week programme and attend all required check-ins and assessments

Who may not be able to join:

You have difficulty completing interviews or have significant problems with movement or mobility
You have a serious or sudden illness before or during the study
You have a current gut or intestinal infection, such as C. difficile, E. coli, Salmonella, or certain other infections (confirm with trial site)
You are allergic to the product being tested in this trial (confirm with trial site for details on what the product contains)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Taipei Medical University

Registry

ClinicalTrials.gov

Start date

20 May 2025

Est. completion

31 August 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Assessment of Questionnaire-Based Changes in Motor and Non-Motor Symptoms in Parkinson's Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov